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Abstract
Background: Diabetic foot ulceration is receiving more attention because of its high amputation and mortality
rate. It is essential to establish the frequency of amputations in people with diabetes after any change to the
management of diabetic foot care. The present study aim to compare the frequency of lower-extremity
amputations in patients with diabetes foot ulcer over a ten-year period.
Methods: Six hundred forty eight patients with diabetes foot ulcer were retrospectively studied from 2004 to 2013.
The clinical features, laboratory results and the lower-extremity amputations were recorded. Major amputation was
defined as amputations above the ankle while minor amputation was amputations below the ankle in the present study.
Results: Patients with diabetic foot ulcer were old (age 66.96 ± 11.96 years), with a long duration of diabetes
(10.30 ± 6.94 years), high HbA1c (9.19 ± 2.62 %), SBP (144.05 ± 24.18 mmHg), DBP (79.53 ± 11.88 mmHg), LDL-C
(2.71 ± 0.93 mmol/L) and had great frequency of neuropathy (62.7 %), retinopathy (45.0 %), nephropathy (39.5 %) and
PAD (33.2 %). From 2004 to 2013, the frequency of all lower-extremity amputations is 12.0 % (5.2 % major amputation,
6.8 % minor amputation). The frequency of major amputations decreased from 9.5 % in 2004 and 14.5 % in 2005 to less
than 5.0 % after 2006. In particular, there was a significant decline in major amputations of diabetic foot patient with
Wagner 3 to 4 wounds. The frequency rate of major amputations in diabetic foot patient with Wagner 3 to 4 wounds
fell from 35.7 % in 2004 to 4.4 % after 2007. The change in frequency of minor amputations was fluctuation.
Conclusion: This study demonstrates that the introduction of a multidisciplinary team, coordinated by an
endocrinologist and a podiatrist, for managing diabetic foot disease is associated with a reduction in the
frequency of major amputations in patients with diabetes.
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Background
In 2011, Chinese Diabetes Society studies have shown
that Chinese diabetic foot disease accounted for 12.4 %
of the hospitalized patients with diabetes in 2010 with a
high amputation rate of 7.3 %, where amputation rates
caused by diabetes accounted for 28.2 % of all amputa-
tions and 41.5 % of non-traumatic amputations, which
stands first on the non-traumatic amputation list [1].
Foot ulceration is one of the most serious and disabling
complications of diabetes mellitus. Diabetic foot ulcer-
ation (DFU) develops in 15 - 25 % of DM patients. It is
the most common cause of nontraumatic foot amputation
worldwide. Approximately 20 % of those cases require am-
putation [2, 3]. DFUs are complex, chronic wounds, which
have a major long-term impact on the morbidity, mortality
and quality of patients’ lives. Furthermore, DFU is respon-
sible for substantial emotional and physical distress as well
as productivity and financial losses that lower the quality
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of life [4]. Because of its high amputation and mortality
rate, DFU is receiving more and more attention as one of
the severe diabetes related complications.
As diabetes is a multi-organ systemic disease, all co-
morbidities that affect wound healing must be managed
by a multidisciplinary team for optimal outcomes with
DFU. Until now, numerous studies have shown that a
multidisciplinary team can reduce amputation rates,
lower costs, and leads to better quality of life for patients
with DFU. A multidisciplinary team can decrease the
risks associated with DFU and amputation by 50 - 85 %
[5, 6]. Since the early 2004, a multidisciplinary team
including nurse, orthopedics, plastic surgery, vascular
surgery, and nutritional department, headed by endocrin-
ology department has been developed in our Hospital.
Education, blood sugar control, wound debridement, ad-
vanced dressing, offloading, surgery, and advanced therap-
ies were used clinically and comprehensively from 2004
and reinforced from 2006. So establishing the frequency of
amputations in people with diabetes after any change to
the management of diabetic foot care is essential, and it is
necessary to know how rates change over time.
The aim of this study was to analyze the effect of the
introduction of multidisciplinary diabetic foot team in
our hospital, by evaluating trends in major and minor
lower-extremity amputation rate in people with DFU in
our department between 2004 and 2013.
Methods
Study population
Medical records of the diabetic inpatients admitted to
the Diabetic Foot Care Center, Department of Endocrin-
ology and Metabolism at the Sun Yat-sen Memorial
Hospital, Sun Yat-sen University from 1 April 2004 to
31 December 2013 were retrospectively reviewed. Foot
ulcer was graded according to Wagner’s classification
[7]: Grade 0, high-risk foot; Grade 1, superficial ulcer;
Grade 2, deep ulcer penetrating to tendon, bone, or
joint; Grade 3, deep ulcer with abscessor osteomyelitis;
Grade 4, localized gangrene; and Grade 5, extensive
gangrene requiring a major amputation. Totally 648 pa-
tients with diabetic foot ulcer at Wagner Grade 1-5
were recruited with 334 males and 314 females. Among
all the 648 patients, 78 patients underwent amputation.
Clinical and biochemical measurements
Detailed records of these patients were retrieved and
available information, including clinical history, labora-
tory profiles, therapeutic course and outcome, were
collected. Age, duration of diabetes and diabetes com-
plications were recorded. Blood pressure was measured.
Laboratory test results, including fasting blood glucose,
glycosylated hemoglobin (HbA1c) and blood lipids were
tested.
Diabetic retinopathy is detected during an eye exam-
ination by ophthalmologist that includes stages 1-4
pathological change (0 = no retinopathy, 1 = mild non-
proliferative retinopathy, 2 =moderate non-proliferative
retinopathy, 3 = severe non-proliferative retinopathy, and
4 = proliferative retinopathy). Diabetic patients with urin-
ary albumin to creatinine ratio greater than 30 mg/g or
24-hour urinary albumin greater than 0.5 g or with ele-
vated serum creatinine were defined as having diabetic ne-
phropathy. Diabetic peripheral neuropathy is the diagnosis
by comprehensive evaluation of the appearance of the feet,
presence of ulceration, ankle reflexes, large fiber neur-
opathy, pressure sensation and nerve conduction tests.
The patient is diagnosed with peripheral arterial disease
(PAD) when the ankle brachial index is ≤ 0.90 or absence
of dorsalis pedis artery pulse or ultrasonography in detect-
ing lower extremity arterial stenosis greater than 50 %.
Amputation was defined as the complete loss of the trans-
verse anatomical plan of any part of the lower limb. All
amputations performed below the ankle were defined as
minor amputations, whereas amputations above the ankle
were defined as major.
In patients with more than one procedure, the highest
level of amputation was analyzed. In cases where patients
underwent multiple amputations during the study period,
the amputation that was deemed to have the largest im-
pact on the patient’s quality of life was used for the ana-
lysis. When patients underwent several amputations on
the same level during an extended period of time, the first
recorded amputation was used. Repeated amputations (re-
amputations) performed within the same period of hos-
pital care, due to poor healing or infection, were classified
as the last reported amputation within this period. Re-
amputations and subsequent amputations of a contralat-
eral limb (double amputations) were analyzed separately.
Statistical analysis
All calculations were performed using SPSS version 13.5
software (SPSS Inc., Chicago, IL, USA). The data were
expressed as means ± SD when variables were normally
distributed. Frequencies and percentages were used for
statistical descriptions. Continuous variables were analyzed
using one way ANOVA. Frequency data were examined
by χ2 test. Statistical significance was defined as P < 0.05.
Results
Clinical characteristics of study subjects
The average age of patients with DFU was 66.96 ±
11.96 years, with mean diabetes duration of 10.30 ±
6.94 years. The overall glucose level was high, with an
average HbA1c of 9.19 ± 2.62 %. Among all the diabetic
foot patients, the frequency of neuropathy, retinopathy,
nephropathy and PAD were 62.67 %, 45.00 %, 39.47 %
and 33.24 %, respectively.
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Clinical pathway of standardized and multidisciplinary
team management
Standardized management pathway of diabetic foot pa-
tients before the multidisciplinary team was shown in
Fig. 1. A multidisciplinary team headed by endocrinology
department was reinforced in our hospital after year 2006,
which including nurse, orthopedics, plastic surgery, vascu-
lar surgery, and nutritional department. Clinical pathway
of patients with diabetic foot ulcer in department of endo-
crinology after introduction of a multidisciplinary team
was shown in Fig. 2.
Demographic and clinical data of DFU patients
We then compared the demographic and clinical data of
DFU patients in each year. No significant difference was
found in age, diabetes duration, SBP, DBP, HbA1c, TC,
LDL-C, TG, HDL-C or creatinine of the patients in each
year (p > 0.05) during 2004-2013. Whereas, there was
significant difference in hospital days (p = 0.015), which
showed an overall downward trend (Table 1).
The demographic and biochemical characteristics of
the study subjects before and after the introduction of a
multidisciplinary team are shown in Table 2. Average
hospital days of patients are the key indication which re-
flects the working efficiency of the management team.
As shown in Table 2, although most measures were not
different before and after multidisciplinary team intro-
duction, the average hospitalization day is significantly
reduced after the multidisciplinary collaboration DF
management team was reinforced in the year 2006.
Wagner grade distribution of DF patients
From 2004 to 2013, proportions of patients at Wagner
grade 1-4 are 9.72 %, 37.81 %, 26.85 %, 23.92 % and
Fig. 1 Standardized management pathway of diabetic foot patients
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1.70 % respectively. We analyzed Wagner grade distribu-
tion in each year and found them significantly different
from one another (P < 0.01). Furthermore, we also tested
distribution of patients at Wagner 3-5 as well as Wagner
3-4, and found no significant difference between each
year (p > 0.05). But when it came to patients at Wagner
1-2, the distribution had significant difference (P < 0.01).
Amputation rate analysis of DFU patients
The average annual amputation rate from 2004 to 2013
was 12.03 %, among which major amputation took
5.24 % and minor amputation took 6.79 %. When being
analyzed by year, major amputation changed from
9.52 %-14.54 % before 2006 to below 5 % after 2006.
Meanwhile, minor amputation fell from above 10 %
(from 11.90 % to 16.36 %) before 2006 to below 10 %
(from 2.72 % to 9.58 %) after 2006, but raised back to
11.45 % in 2013 (Fig. 3).
Amputation rates in different Wagner Grade
Among the 308 patients at Wagner grade 1-2 from 2004
to 2013, 6 underwent amputation, including 2 minor
Fig. 2 Clinical pathway of diabetic foot ulcer (and or gangrene) patients in department of endocrinology
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amputations and 1 major amputation in 2004, 2 minor
amputations in 2012, and 1 minor amputation in 2013.
There was no amputation in the rest of the years. Pa-
tients at Wagner grade 5 during the 10 years added up
to 11, among whom 4 underwent minor amputations
and 2 suffered from major amputations. The amputation
rate in hospital was 54.55 %.
During 2004-2013, major amputation rate of DFU pa-
tients at Wagner grade 3-4 significantly reduced in 2006
and stayed below 5 % since then (Fig. 4). Minor amputa-
tion rate also went down in 2006, but somehow appeared
a little rebound later. Meanwhile, statistical analysis of
clinical data of all the patients showed a downtrend in
length of hospital days (P = 0.001), but no significant dif-
ference was found in age, diabetes duration, SBP, DBP,
HbA1c, TC, LDL-C, TG, HDL-C and creatinine levels.
Discussion
In the present study, we found that the introduction of a
multidisciplinary team in the treatment of DFU was as-
sociated with a reduction in the frequency of major am-
putations in patients with diabetes. This study is the first
from China to report a reduction in major amputations
following introduction of a multidisciplinary diabetic
foot team.
The amputation risk varied according to different con-
dition of the diabetic foot. Patients at Wagner grade 1-2
had relatively mild foot problem so as the amputation
rate was low and prognosis was good. However, patients
at Wagner grade 3-5 suffered from more severe condition
as well as high amputation risk and great harm [2, 3].
According to their Wagner grades, we analyzed the am-
putation rate of DFU patients. During 2004-2013, the
Fig. 3 The amputation rate analysis of DFU patients from 2004 to 2013 (Major amputation: amputations above the ankle; Minor amputation:
amputations below the ankle)
Fig. 4 Amputation rates in patients at Wagner grade 3-4 across time (Major amputation: amputations above the ankle; Minor amputation:
amputations below the ankle)
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Table 1 The clinical characteristics of patients with DFU from 2004 to 2013
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 p
number 42 55 36 56 73 54 110 72 54 96
Age (years) 67.25±11.42 68.10±11.68 70.24±9.27 68.76±10.88 67.40±11.60 68.43±12.25 66.52±12.32 64.35±13.13 65.62±11.85 66.14±12.41 0.324
Duration of diabetes (years) 8.83±5.00 9.40±5.98 10.42±6.80 9.75±6.78 11.20±8.1 8.82±5.47 11.34±7.54 10.11±7.76 9.64±6.07 10.1±6.78 0.297
SBP (mmHg) 142.92±25.07 141.04±22.22 145.76±27.39 142.61±21.76 138.88±22.92 145.59±21.89 141.13±19.27 140.76±23.52 142.70±24.60 140.30±20.50 0. 36
DBP(mmHg) 80.32±11.73 79.96±14.60 78.32±10.41 80.68±10.78 79.21±9.48 79.04±14.23 78.07±13.79 79.19±9.79 80.34±12.73 79.84±9.97 0.87
BMI (kg/m2) 20.80±6.16 19.63±8.55 20.83±7.87 21.62±5.45 20.09±7.38 21.35±7.13 22.15±6.43 20.49±6.32 20.74±7.57 21.90±5.93 0.744
HbAlc (%) 9.60±3.09 8.88±2.50 9.16±2.33 10.55±4.40 8.86±2.12 9.54.±2.72 9.01±2.67 8.97±2.45 9.20±3.42 8.87±3.02 0.92
LDL-C (mmol/L) 2.47±0.91 2.83±1.10 2.65±0.75 2.77±0.78 2.94±0.98 2.51±0.92 2.43±0.87 2.66±0.91 2.69±0.91 2.80±1.13 0.06
TG (mmol/L) 1.29±1.04 1.47±1.31 1.39±0.87 1.69±1.74 1.57±0.99 1.63±1.66 1.39±0.74 1.54±1.34 1.75±1.43 1.64±1.27 0.30
HDL-C (mmol/L) 1.08±0.37 1.02±0.36 0.97±0.32 1.10±0.38 1.08±0.93 097±0.25 0.98±0.35 1.12±0.40 1.04±0.78 0.98±0.33 0.45
Cr (μmol/L) 136.08±111.97 129.92±96.19 128.61±111.14 129.02±81.71 125.98±64.70 131.08±68.28 123.53±85.15 130.02±70.08 129.83±89.75 127.67±90.27 0.98
Hospital days (days) 32.62±26.24 31.00±28.34 26.57±29.05 24.30±18.20 26.57±21.69 21.20±17.79 20.75±13.10 19.37±11.17 21.46±14.70 20.16±15. 35 0.015















amputation rate of DFU patients at Wagner grade 1-2
was 1.95 %, with no changing in the last 10 years. At
the same time, amputation rate of patients at Wagner
grade 3-4 was 19.47 % and changed greatly during the
last 10 years.
Another interesting phenomenon we found in the
study was that minor amputation (below the ankle) of DF
patients at Wagner grade 3-4 also showed a downward
trend, but appeared significant fluctuation. Krishnan [8]
and Jorgensen [9] et al. observed similar phenomenon in
diabetes patients that major amputation rate decreased
significantly while minor amputation had little change and
obvious fluctuation. It might be attributed to the following
reason that patients who used to need major amputation
operation acquired lower amputation level after receiving
proper treatment, making minor amputation take place of
the major amputation, which definitely proved the effect-
iveness of our management
Based on the previous researches, there are many factors
that determine the amputation rate [10–14]. Old age,
smoking, diabetes duration, diabetes chronic complications
as DN and DR, and other co-morbidities like hypertension
are all risk factors of amputation of DF patients. The com-
plicated condition of DF patients made the treatment really
difficult, therefore brought long treatment period, high risk
and high amputation rate. Therefore, our medical treat-
ment was carried out based on those risk factors and in line
with the recommendations of the International Consensus
on the Diabetic Foot [15], and the trend of diabetic foot
ulceration amputation appeared in our department was
in accord with other counties reported in the correspond-
ing period of time. Thus, we can draw the conclusion that
disciplinary comprehensive management of DF patients is
effective with no doubt.
To our great amazement, amputation rate of DFU pa-
tients in our department during 2004-2013 changed ac-
cordantly with our management level, especially in those
at Wagner grade 3-4. In retrospect, the improvement of
DF management in our department can be divided into
two periods roughly.
From 2004, we began to set up standard management
of DF patients in our department and explored a proper
management pattern. In this period, we trained a med-
ical team of passionate doctors and nurses who were
skilled with DF patients’ treatment. Furthermore, we
built DF workshop and accomplished plantar pressure
measurement of normal people and diabetes mellitus pa-
tients. By means of new-type dressing, epidermal growth
factors and therapeutic pressure-lowing footwear, we
gradually built up multidisciplinary collaboration oper-
ation pattern. During this period, DFU patients’ major
amputation rate reduced from 35.71 % in 2004, 31.82 %
in 2005, to 11.11 % in 2006, especially in those at Wagner
grade 3-4.
After 2006, the multidisciplinary collaboration DF man-
agement team was reinforced. Multidisciplinary consult-
ation and collaboration operation pattern were built and
treatment techniques like negative pressure wound ther-
apy and ultrasonic debridement were introduced. We also
pioneered the operation of lower extremity arterial inter-
ventional therapy in endocrinology department. Further-
more, clinical management pathway of DF disease was set
up and improved with time. In this period of time, major
amputation of DF patients at Wagner grade 3-4 appeared
further reduction than years before 2006, as the average
major amputation rate was 4.44 %.
This study has several limitations. First, the results of
the present study only included Chinese subjects and
might not be representative of other groups. Second, all
invited participants in the present study were at the
single-center level, which was a convenience sample and
selection bias is inevitable. Third, although we did find
that the introduction of a multidisciplinary team for
managing diabetic foot disease is associated with a re-
duction in the frequency of major amputations, other
potential mediators such as compliance of treatment,
and prognostic evaluation such as hospitalization ex-
penses and DFU mortality were not evaluated in the
present study. Fourth, due to the retrospective design of
the current study, we should cautiously interpret the
present finding, especially because it is subject to sub-
stantial recall bias. Fifth, the present study only includes
648 diabetes patients, further prospective studies with
larger sample size are needed to determine the precise
value of multidisciplinary team in management of diabetic
foot disease.
Table 2 Characteristics of study patients Wagner grade 3-4









SBP (mmHg) 142.62±23.58 142.65±23.81 0.995
DBP (mmHg) 76.16±12.30 79.34±12.07 0.128
BMI 19.52±7.73 21.17±6.17 0.183
Cr (μmol/L) 118.87±80.39 120.63±58.94 0.886
HbAlc (%) 9.84±2.52 9.67±2.69 0.771
TC (mmol/L) 4.22±0.98 4.22±1.15 0.992
LDL-C (mmol/L) 2.70±1.02 2.68±0.89 0.931
TG (mmol/L) 1.14±0.74 1.53±1.50 0.074




SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass index,
Cr serum creatinine, TG triglycerides, TC total cholesterol, HDL-C high-density
lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol
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Conclusion
In conclusion, this study demonstrates that the introduc-
tion of a multidisciplinary team for managing the diabetic
foot, headed by endocrinology department is associated
with a reduction in the frequency of major amputations in
patients with diabetes in China.
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